Article

Percepta Genomic Sequencing Classifier And Decision-Making In Patients With High-Risk Lung Nodules: A Decision Impact Study

2021-09-02

Abstract excerpt

<h4>Background: </h4> Incidental and screening-identified lung nodules are common, and a bronchoscopic evaluation is frequently nondiagnostic. The Percepta Genomic Sequencing Classifier (GSC) is a genomic classifier developed in current and former smokers which can be used for further risk stratification in these patients. Percepta GSC has the capability of up-classifying patients with a pre-bronchoscopy risk that...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a06e3332-d56e-5757-b08c-9263fe67652c
DOI: 10.21203/rs.3.rs-767400/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Percepta Genomic Sequencing Classifier And Decision-Making In Patients With High-Risk Lung Nodules: A Decision Impact StudyDOI 10.21203/rs.3.rs-767400/v1Read

Comparing Modalities for Risk Assessment in Patients with Pulmonary Lesions and Nondiagnostic Bronchoscopy for Suspected Lung CancerSemantic proximity Read

Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.Semantic proximity Read

Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancerSemantic proximity Read

Modeling the Pretest Probability of Identifying Druggable Mutations in Lung Cancer Using Nationwide Comprehensive Genomic Profiling Data.Semantic proximity Read

AI-Based Computational Pathology for Precision Lung Cancer Management: A Systematic Review and Meta-Analysis of Diagnostics and Prognostic AlgorithmsSemantic proximity Read

Detecting pulmonary malignancy against benign nodules using noninvasive cell-free DNA fragmentomics assaySemantic proximity Read

TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer riskSemantic proximity Read

Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung Cancer.Semantic proximity Read

Predictive radiogenomics modeling of EGFR mutation status in lung cancer.Semantic proximity Read

Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study.Semantic proximity Read

Correlation analysis of clinical, pathological, imaging and genetic features of ground-glass nodule featured lung adenocarcinomas between high-risk and non-high-risk individualsSemantic proximity Read

Explainable Machine Learning to Identify Patient-specific Biomarkers for Lung CancerSemantic proximity Read